Hagos Tasew Atalay

TL;DR: The Global Burden of Disease (GBD) study as discussed by the authors has been used to describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning, including cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs).

TL;DR: Although improvements in water and sanitation remain essential, increased vaccine use and improved data and surveillance to inform vaccine rollout are likely to drive the greatest improvements in the global burden of the disease.

TL;DR: This comprehensive assessment of the burden of influenza LRTIs shows the substantial annual effect of influenza on global health, and preparedness planning for potential pandemics should not be overlooked, and vaccine use should be considered.

TL;DR: The findings highlight the large global inequities in congenital heart disease and can serve as a starting point for policy changes to improve screening, treatment, and data collection.

TL;DR: The findings show that there have been substantial but uneven declines in LRI mortality among countries between 1990 and 2017 and changes in exposure to modifiable risk factors are related to the rates of decline in L RI mortality.